A STUDY TO ASSESS EFFICACY, SAFTETY AND PHARMACOKINETICS OF EYU688 IN HEALTHY PARTICIPANTS CHALLENGED WITH DENGUE SEROTYPE 2

Johns Hopkins University, Baltimore MD

Investigators

Abstract

To support a phase two clinical trial to evaluate a dengue vaccine candidate.